Main public logs

Combined display of all available logs of Azupedia. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

• 20:58, 12 April 2024 Fire talk contribs created page Translations:Calcifediol/7/ja (Created page with "==ビタミンD欠乏症の血液検査{{Anchor|Blood test for vitamin D deficiency}}== {{main/ja|Vitamin D/ja#Recommended serum levels}} 医学検査では、25-ヒドロキシビタミンD（25(OH)D）の血液検査を行い、ビタミンDの状態を判定する。 25(OH)Dという名称は、ビタミンD₃に由来するカルシフェジオール（25-ヒドロキシ-コレカルシフェロール）と、ビタミンD₂に由来するエル...")
• 20:55, 12 April 2024 Fire talk contribs created page Translations:Calcifediol/6/ja (Created page with "カルシフェジオールはまた、24-水酸化によって24,25-ジヒドロキシコレカルシフェロールに変換される。この酵素反応はCYP24A1によって行われ、腎臓を含む多くのビタミンD標的組織に発現しており、カルシトリオールによって誘導される。これはカルシトリオールをカルシトロ酸に不活性化するが、2...")
• 20:55, 12 April 2024 Fire talk contribs created page Translations:Calcifediol/5/ja (Created page with "カルシフェジオールは腎臓でさらに1α位で水酸化され、1,25-(OH)₂D₃、カルシトリオールを形成する。この酵素的25(OH)D-1α-ヒドロキシラーゼ反応はCYP27B1によってのみ行われ、腎臓では主に副甲状腺ホルモンによって制御されるが、FGF23やカルシトリオール自体によ...")
• 20:53, 12 April 2024 Fire talk contribs created page Translations:Calcifediol/4/ja (Created page with "コレカルシフェロールの一般的な摂取量（最大2000IU/日）では、カルシフェジオールへの変換は急速である。 大量摂取（100,000IU）の場合、カルシフェジオール濃度がピークに達するまでに7日間かかる。 カルシフェジオールは血中ではビタミンD結合蛋白（gc-グロブリンとしても知られる）と結合し、主な循環ビタミンD代謝産物である。カルシフェジオー...")
• 20:53, 12 April 2024 Fire talk contribs created page Translations:Calcifediol/3/ja (Created page with "==生化学{{Anchor|Biology}}== カルシフェジオールは、活性型ビタミンDであるカルシトリオールの前駆体であり、肝臓でコレカルシフェロール（ビタミンD₃）の25位を水酸化することにより合成される。この酵素的な25位水酸化酵素反応は、ミクロソームに存在するCYP2R1の作用によるところが大きいが、mitochondrial/ja|ミトコンド...")
• 20:44, 12 April 2024 Fire talk contribs created page Translations:Calcifediol/17/ja (Created page with "==研究{{Anchor|Research}}== 骨粗鬆症の予防と治療において、カルシフェジオールとコレカルシフェロールを含む他のビタミンDの効果を比較する研究が進行中である。")
• 20:44, 12 April 2024 Fire talk contribs created page Translations:Calcifediol/18/ja (Created page with "== こちらも参照 == * Hypervitaminosis D/ja * Hypovitaminosis D/ja * ビタミン D")
• 20:43, 12 April 2024 Fire talk contribs created page Translations:Calcifediol/19/ja (Created page with "{{Vitamins/ja}} {{Calcium homeostasis/ja}} {{Vitamin D receptor modulators/ja}} {{Portal bar | Medicine}}")
• 20:43, 12 April 2024 Fire talk contribs created page Translations:Calcifediol/20/ja (Created page with "Category:Vitamin D Category:Secosteroids Category:Vinylidene compounds")
• 20:43, 12 April 2024 Fire talk contribs created page Translations:Calcifediol/2/ja (Created page with "カルシフェジオールは血液中でビタミンD結合タンパク質と強く結合している。血清カルシフェジオールの測定は、ビタミンD欠乏または充足を示すために、人のビタミンDの状態を決定するために行われる通常の検査である。カルシフェジオールは、ビタミンDを補充する経口医薬品として一部の国で販売され...")
• 20:41, 12 April 2024 Fire talk contribs created page Translations:Calcifediol/1/ja (Created page with "{{chembox | Verifiedfields = changed | verifiedrevid = 480474501 | ImageFile = Calcidiol2.svg | ImageAlt = カルシフェジオールの骨格式 | ImageFile1 = Calcifediol 3D ball.png | ImageAlt1 = カルシフェジオール分子のボール＆スティックモデル | PIN = (1''S'',3''Z'')-3-[(2''E'')-2-<nowiki/>{(1''R'',3a''S'',7a''R'')-1-[(2''R'')-6-Hydroxy-6-methylheptan-2-yl]-7a-methyloctahydro-4''H''-inden-4-ylidene}ethylidene]-4-methylidenecyclohexan-1-ol | O...")
• 20:40, 12 April 2024 Fire talk contribs created page Calcifediol/ja (Created page with "カルシフェジオール") Tags: Mobile edit Mobile web edit
• 20:39, 12 April 2024 Fire talk contribs created page Translations:Calcifediol/Page display title/ja (Created page with "カルシフェジオール")
• 20:39, 12 April 2024 Fire talk contribs marked Calcifediol for translation
• 20:39, 12 April 2024 Fire talk contribs set the priority languages for translatable page Calcifediol to Japanese
• 20:33, 12 April 2024 Fire talk contribs created page secondary hyperparathyroidism (Q22016) (wbeditentity-create:2|en: secondary hyperparathyroidism, human disease)
• 20:33, 12 April 2024 Fire talk contribs created page secondary hyperparathyroidism of renal origin (Q22015) (wbeditentity-create:2|en: secondary hyperparathyroidism of renal origin, Human disease)
• 20:30, 12 April 2024 Fire talk contribs created page rare genetic parathyroid disease and phosphocalcic metabolism disorder (Q22014) (wbeditentity-create:2|en: rare genetic parathyroid disease and phosphocalcic metabolism disorder, human disease)
• 20:28, 12 April 2024 Fire talk contribs created page rare genetic bone disease (Q22013) (wbeditentity-create:2|en: rare genetic bone disease, Rare genetic bone disease)
• 20:27, 12 April 2024 Fire talk contribs created page rare genetic bone development disorder (Q22012) (wbeditentity-create:2|en: rare genetic bone development disorder, human disease)
• 20:26, 12 April 2024 Fire talk contribs created page primary bone dysplasia (Q22011) (wbeditentity-create:2|en: primary bone dysplasia, human disease)
• 20:25, 12 April 2024 Fire talk contribs created page primary bone dysplasia with defective bone mineralization (Q22010) (wbeditentity-create:2|en: primary bone dysplasia with defective bone mineralization, human disease)
• 20:24, 12 April 2024 Fire talk contribs created page rare parathyroid disease and phosphocalcic metabolism anomaly (Q22009) (wbeditentity-create:2|en: rare parathyroid disease and phosphocalcic metabolism anomaly, human disease)
• 20:23, 12 April 2024 Fire talk contribs created page disorders of vitamin D metabolism (Q22008) (wbeditentity-create:2|en: disorders of vitamin D metabolism, human disease)
• 20:22, 12 April 2024 Fire talk contribs created page vitamin D deficiency (Q22007) (wbeditentity-create:2|en: vitamin D deficiency, human disease commonly occurring in people when they have inadequate sunlight exposure)
• 20:20, 12 April 2024 Fire talk contribs created page metabolic bone disease (Q22006) (wbeditentity-create:2|en: metabolic bone disease, disease)
• 20:17, 12 April 2024 Fire talk contribs created page (23S)-23,25-dihydroxycalciol (Q22005) (wbeditentity-create:2|en: (23S)-23,25-dihydroxycalciol, chemical compound)
• 20:15, 12 April 2024 Fire talk contribs created page 25-hydroxycholecalciferol-23-hydroxylase activity (Q22004) (wbeditentity-create:2|en: 25-hydroxycholecalciferol-23-hydroxylase activity, Catalysis of the reaction: calcidiol + 2 H(+) + O2 + 2 reduced [adrenodoxin] = (23S)-23,25-dihydroxycalciol + H2O + 2 oxidized [adrenodoxin].)
• 20:10, 12 April 2024 Fire talk contribs created page vasoconstriction (Q22003) (wbeditentity-create:2|en: vasoconstriction, narrowing of blood vessels by the constriction of smooth muscle cells)
• 20:09, 12 April 2024 Fire talk contribs created page vasoconstrictor agents (Q22002) (wbeditentity-create:2|en: vasoconstrictor agents, drugs used to cause constriction of the blood vessels)
• 10:49, 12 April 2024 Fire talk contribs created page calcium channel agonists (Q22001) (wbeditentity-create:2|en: calcium channel agonists, Agents that increase calcium influx into calcium channels of excitable tissues. This causes vasoconstriction in vascular smooth muscle and/or cardiac muscle cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-se)
• 10:45, 12 April 2024 Fire talk contribs created page autoimmune skin disease (Q22000) (wbeditentity-create:2|en: autoimmune skin disease, hypersensitivity reaction type II disease that is the abnormal functioning of the immune system that causes your immune system to produce antibodies or T cells against cells and/or tissues in the skin and connective tissue)
• 10:44, 12 April 2024 Fire talk contribs created page psoriasis (Q21999) (wbeditentity-create:2|en: psoriasis, skin disease)
• 10:43, 12 April 2024 Fire talk contribs created page antipsoriatic (Q21998) (wbeditentity-create:2|en: antipsoriatic, drug used to treat psoriasis)
• 10:40, 12 April 2024 Fire talk contribs created page hyperparathyroidism (Q21997) (wbeditentity-create:2|en: hyperparathyroidism, endocrine disease)
• 10:38, 12 April 2024 Fire talk contribs created page vitamin D 23-hydroxylase activity (Q21996) (wbeditentity-create:2|en: vitamin D 23-hydroxylase activity, Catalysis of the hydroxylation of C-23 of any form of vitamin D.)
• 10:37, 12 April 2024 Fire talk contribs created page 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity (Q21995) (wbeditentity-create:2|en: 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity, Catatlysis of the reaction: calcitriol + 2 H(+) + O2 + 2 reduced [adrenodoxin] = 1alpha,23S,25-trihydroxycholecalciferol + H2O + 2 oxidized [adrenodoxin].)
• 10:35, 12 April 2024 Fire talk contribs created page calcitriol binding (Q21994) (wbeditentity-create:2|en: calcitriol binding, Interacting selectively and non-covalently with calcitriol. Calcitriol (1,25-dihydroxycholecalciferol) is the hormonally active form of vitamin D3.)
• 10:30, 12 April 2024 Fire talk contribs created page calcitriol (Q21993) (wbeditentity-create:2|en: calcitriol, vitamin D)
• 10:26, 12 April 2024 Fire talk contribs created page calcidiol 1-monooxygenase activity (Q21992) (wbeditentity-create:2|en: calcidiol 1-monooxygenase activity, Catalysis of the reaction: calcidiol + H(+) + NADPH + O(2) = calcitriol + H(2)O + NADP(+).)
• 10:24, 12 April 2024 Fire talk contribs created page calcidiol binding (Q21991) (wbeditentity-create:2|en: calcidiol binding, Interacting selectively and non-covalently with calcidiol.)
• 10:20, 12 April 2024 Fire talk contribs created page calcifediol (Q21990) (wbeditentity-create:2|en: calcifediol, chemical compound)
• 10:18, 12 April 2024 Fire talk contribs created page Template:Calcium homeostasis/ja (Created page with "{{Navbox | name = Calcium homeostasis/ja | title = カルシウム恒常性 (H05) | state = {{{state<includeonly>|autocollapse</includeonly>}}} | listclass = hlist | group1 = 副甲状腺ホルモンとその類似体 | list1 = * Recombinant human parathyroid hormone/ja * Abaloparatide/ja * Teriparatide/ja | group2 = 抗副甲状腺ホルモン剤 | list2 = {{Navbox|sub...")
• 10:17, 12 April 2024 Fire talk contribs created page Template:Calcium homeostasis (Created page with "{{Navbox | name = Calcium homeostasis | title = Calcium homeostasis (H05) | state = {{{state<includeonly>|autocollapse</includeonly>}}} | listclass = hlist | group1 = Parathyroid hormone and analogues | list1 = * Recombinant human parathyroid hormone * Abaloparatide * Teriparatide | group2 = Anti-parathyroid hormone agents | list2 = {{Navbox|subgroup | group1 = Calcitonin derivatives | list1 = * Calcitonin * [...")
• 10:16, 12 April 2024 Fire talk contribs created page Calcifediol (Created page with "{{short description|Chemical compound}} {{chembox | Verifiedfields = changed | verifiedrevid = 480474501 | ImageFile = Calcidiol2.svg | ImageAlt = Skeletal formula of calcifediol | ImageFile1 = Calcifediol 3D ball.png | ImageAlt1 = Ball-and-stick model of the calcifediol molecule | PIN = (1''S'',3''Z'')-3-[(2''E'')-2-<nowiki/>{(1''R'',3a''S'',7a''R'')-1-[(2''R'')-6-Hydroxy-6-methylheptan-2-yl]-7a-methyloctahydro-4''H''-inden-4-ylidene}ethylidene]-4-methylidenecyclohexan-...")
• 10:09, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/34/ja (Created page with "研究者らは、この化合物は前世代の抗凝固殺鼠剤（ワルファリンやコンジェナー）やブロメタリンよりも非標的種に対する毒性が低く、リレー中毒（毒殺された動物を食べることによる中毒）は記録されていないと報告している。とはいえ、殺鼠剤中のコレカルシフェロール...")
• 10:08, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/33/ja (Created page with "高用量のコレカルシフェロールの機序は、「高カルシウム血症を引き起こし、その結果、軟部組織の全身石灰化が起こり、腎不全、心臓異常、高血圧、中枢神経系抑制、および消化器系不調を引き起こす。徴候は一般に摂取後18～36時間以内に発現し、抑うつ、食欲不振、polyuri...")
• 10:06, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/32/ja (Created page with "==殺虫剤{{Anchor|Pesticide}}== げっ歯類は他の種よりも高用量にやや弱く、コレカルシフェロールはこれらの害虫駆除のために毒餌に使用されてきた。")
• 10:05, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/31/ja (Created page with "==安定性== コレカルシフェロールはUV放射に非常に敏感で、速やかに、しかし可逆的に分解して超ステロールを形成し、さらに不可逆的にエルゴステロールに変換する。")
• 10:05, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/30/ja (Created page with "コレカルシフェロールは、地衣類からビタミンサプリメント用に工業生産もされており、菜食主義者にも適している。")